País: Australia
Idioma: inglés
Fuente: Department of Health (Therapeutic Goods Administration)
mycophenolate mofetil, Quantity: 500 mg
Arrotex Pharmaceuticals Pty Ltd
Mycophenolate mofetil
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; croscarmellose sodium; povidone; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; macrogol 4000; polyvinyl alcohol; iron oxide black; lecithin
Oral
50 tablets
(S4) Prescription Only Medicine
Prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. ,Prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.
Visual Identification: Lavender, convex, capsule-shaped tablet with "MO 500" on one side and Arrow logo on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2012-01-18